There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Actinium Pharmaceuticals (ATNM – Research Report) and Bristol Myers (BMY – Research Report) with bullish sentiments. Actinium Pharmaceuticals (ATNM) In a report issued on November 19, Matt Phipps from William Blair maintained a Buy rating on Actinium Pharmaceuticals. The company's shares closed last Friday at $7.62. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-actinium-pharmaceuticals-atnm-and-bristol-myers-bmy?utm_source=advfn.com&utm_medium=referral
Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Actinium Pharmaceuticals Charts.
Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Actinium Pharmaceuticals Charts.